Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Cleveland, Ohio


Purpose:

This trial is for patients with acute occlusion of one of the arteries supplying blood to the leg. The trial is designed to determine the safety and activity of a novel clot dissolving (thrombolytic) drug (alfimeprase).


Criteria:

- Patients with acute peripheral arterial occlusion of the lower limb (onset of symptoms within 14 days) - Rutherford Class I or IIa (minimal sensory loss, no muscle weakness, audible venous flow) - Age 18 or above - Able to consent - Able to follow up


NCT ID:

NCT00073554


Primary Contact:

N/A


Backup Contact:

N/A


Location Contact:

Cleveland, Ohio
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: December 11, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.